The pharmaceutical darling that has brought billions in revenue to Pfizer over the past 15 years will now share the shelves with its generic competitors.
The Scientist
Most Recent
A special glucose molecule makes tumor cells more vulnerable to a pair of cancer cell-killing drugs.
New congressional proposals would allow drug makers to bypass traditional clinical trial requirements for drugs that address rare diseases.
Are pharmaceuticals in the environment affecting human health?
Researchers scan the molecules in spider venom for anti-cancer effects in tissue culture.
Dwindling stocks in more than a dozen cancer drugs are delaying clinical trials.
The US government agency vows to improve the way it facilitates the development and approval of drugs for orphan diseases.
Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.
A new database helps scientist predict new uses for existing drugs.
The US federal agency issues draft rules to guide medical device makers and those hoping to register biomarkers.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
